Gilead Sciences to acquire Immunomedics in a $21 billion deal
SACRAMENTO: Gilead Sciences Inc. and Immunomedics have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88/share in cash. The transaction,...
Pro Medicus signs 5-year platform deal with Palo Alto based Nines
MELBOURNE: Pro Medicus Limited’s wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 5-year, multi-million dollar contract with Palo Alto based Nines. Nines is co-founded...